User profiles for Carla Palleis

Carla Palleis

Resident in Neurology, Ludwig-Maximilians-Universität Munich
Verified email at med.uni-muenchen.de
Cited by 1075

[HTML][HTML] Deep brain stimulation programming for movement disorders: current concepts and evidence-based strategies

T Koeglsperger, C Palleis, F Hell, JH Mehrkens… - Frontiers in …, 2019 - frontiersin.org
Deep brain stimulation (DBS) has become the treatment of choice for advanced stages of
Parkinson's disease, medically intractable essential tremor, and complicated segmental and …

[HTML][HTML] Deep brain stimulation programming 2.0: future perspectives for target identification and adaptive closed loop stimulation

F Hell, C Palleis, JH Mehrkens, T Koeglsperger… - Frontiers in …, 2019 - frontiersin.org
Deep brain stimulation has developed into an established treatment for movement disorders
and is being actively investigated for numerous other neurological as well as psychiatric …

Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

…, S Tahirovic, M Willem, M Deussing, C Palleis… - Science translational …, 2021 - science.org
2-Deoxy-2-[ 18 F]fluoro-d-glucose positron emission tomography (FDG-PET) is widely used
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …

[HTML][HTML] A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases

…, B Meyer, J Gempt, PH Kuhn, M Simons, C Palleis… - …, 2023 - thelancet.com
A major evolution from purely clinical diagnoses to biomarker supported clinical diagnosing
has been occurring over the past years in neurology. High-throughput methods, such as next…

Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy

…, K Marek, L Beyer, M Song, C Palleis… - JAMA …, 2020 - jamanetwork.com
Importance Progressive supranuclear palsy (PSP) is a 4-repeat tauopathy. Region-specific
tau aggregates establish the neuropathologic diagnosis of definite PSP post mortem. Future …

[HTML][HTML] Tau deposition patterns are associated with functional connectivity in primary tauopathies

…, S Hummel, A Müller, A Finze, C Palleis… - Nature …, 2022 - nature.com
Tau pathology is the main driver of neuronal dysfunction in 4-repeat tauopathies, including
cortico-basal degeneration and progressive supranuclear palsy. Tau is assumed to spread …

[PDF][PDF] Distinct molecular profiles of skull bone marrow in health and neurological disorders

…, VWY Kan, S Besson-Girard, S Katzdobler, C Palleis… - Cell, 2023 - cell.com
The bone marrow in the skull is important for shaping immune responses in the brain and
meninges, but its molecular makeup among bones and relevance in human diseases remain …

Microglial activation and connectivity in Alzheimer disease and aging

…, D Janowitz, K Buerger, M Ewers, C Palleis… - Annals of …, 2022 - Wiley Online Library
Objective Alzheimer disease (AD) is characterized by amyloid β (Aβ) plaques and neurofibrillary
tau tangles, but increasing evidence suggests that neuroinflammation also plays a key …

Cortical [18F]PI‐2620 Binding Differentiates Corticobasal Syndrome Subtypes

C Palleis, M Brendel, A Finze, E Weidinger… - Movement …, 2021 - Wiley Online Library
Background Corticobasal syndrome is associated with cerebral protein aggregates composed
of 4‐repeat (~50% of cases) or mixed 3‐repeat/4‐repeat tau isoforms (~25% of cases) or …

Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET

…, A Nitschmann, M Scheifele, C Palleis… - Journal of cerebral …, 2021 - journals.sagepub.com
The novel tau-PET tracer [ 18 F]PI-2620 detects the 3/4-repeat-(R)-tauopathy Alzheimer’s
disease (AD) and the 4R-tauopathies corticobasal syndrome (CBS) and progressive …